Abstract
This study evaluates a correlation between family history, micronutrients intake, and alternative therapies with genetic instability, before and during breast cancer treatment. For this study, a total of 150 women were selected. Among those, 50 women were breast cancer patients on chemotherapy, while 50 breast cancer patients were on radiotherapy, and 50 were healthy females. All the participants signed the informed consent form and answered the public health questionnaire. Samples of buccal epithelial and peripheral blood cells were collected and analyzed through micronucleus and comet assays. The cells were evaluated for apoptosis and DNA damage. Results showed the association of patients’ family history with an increase in toxicogenetic damage before and during cancer therapy. On the other hand, patients with late-onset cancer also presented genetic instability before and during therapy, along with those who did not take sufficient vegetables and alternative therapies. A positive correlation was observed between the genetic instability and alternative therapies, while inverse correlation was recorded with the vegetable consumption. Results clearly explain that the nutritional aspects and alternative therapies influence the genetic instability before and during cancer therapies especially in radiotherapy treated patients. Our data could be used for the monitoring therapies and management of breast cancer patients.
Similar content being viewed by others
References
Tabrez, S., Priyadarshini, M., Urooj, M., Shakil, S., Ashraf, G. M., Khan, M. S., Kamal, M. A., Alam, Q., Jabir, N. R., Abuzenadah, A. M., Chaudhary, A. G. A., & Damanhouri, G. A. (2013). Cancer chemoprevention by polyphenols and their potential application as nanomedicine. Journal of Environmental Science and Health Part C Environmental Carcinogenesis & Ecotoxicology Reviews, 31, 67–98.
Jabir, N., Firoz, C., Bhushan, A., Tabrez, S., & Kamal, M. (2018). The use of azoles containing natural products in cancer prevention and treatment: an overview. Anti-Cancer Agents in Medicinal Chemistry, 18, 6–14.
Jabir, N. R., Ahmad, S., & Tabrez, S. (2018). An insight on the association of glycation with hepatocellular carcinoma. Seminars in Cancer Biology, 49, 56–63.
Vaidya, A. M., Chetlen, A. L., & Schetter, S. E. (2015). Does a high-risk recommendation in mammography reports increase attendance at a breast cancer risk assessment clinic? Journal of the American College of Radiology, 12, 923–929.
Smith, M., Spence, M. A., & Flodman, P. (2009). Nuclear and mitochondrial genome defects in autisms. Annals of the New York Academy of Sciences, 1151, 102–132.
Arraras, J. I., Manterola, A., Asin, G., Illarramendi, J. J., Cruz, S. d. l., Ibañez, B., Delfrade, J., Salgado, E., Zarandona, U., Cambra, K., Vera, R., & Dominguez, M. A. (2016). Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study. Breast, 26, 46–53.
Abdel-Zaher, A. M., & Eldeib, A. M. (2016). Breast cancer classification using deep belief networks. Expert Systems with Applications, 46, 139–144.
Collier, R. (2017). Half of Canadians can expect cancer diagnosis during lifetime. CMAJ, 189, E920–E920.
INCA. (2016) Instituto Nacional de Câncer: Brazil, Cancer Incidence, http://www.inca.gov.br/estimativa/2016/estimativa-2016-v2011.pdf.
Thomson, A. K., Heyworth, J. S., Girschik, J., Slevin, T., Saunders, C., & Fritschi, L. (2014). Beliefs and perceptions about the causes of breast cancer: a case-control study. BMC Research Notes, 7, 558.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144, 646–674.
Burrell, R. A., & Swanton, C. (2014). Tumour heterogeneity and the evolution of polyclonal drug resistance. Molecular Oncology, 8, 1095–1111.
Rodrigues, L., de Oliveira, A., Tabrez, S., Shakil, S., Khan, M., Asghar, M., Matias, B., Batista, J., Rosal, M., de Lima, M., Gomes, S., de Carvalho, R., de Moraes, G., de Alencar, M., Islam, M., & de Carvalho Melo Cavalcante, A. (2018). Mutagenic, antioxidant and wound healing properties of Aloe vera. Journal of Ethnopharmacology, 227, 191–197.
Deshmukh, A. L., Kumar, C., Singh, D. K., Maurya, P., & Banerjee, D. (2016). Dynamics of replication proteins during lagging strand synthesis: a crossroads for genomic instability and cancer. DNA Repair (Amst), 42, 72–81.
Jabir, N., Islam, M., Tabrez, S., Shakil, S., Zaidi, S., Khan, F., da Silva Araújo, L., de Meneses, A., de Oliveira Santos, J., & de Carvalho Melo Cavalcante, A. (2018). An insight towards anticancer potential of major coffee constituents. Biofactors, 44, 315–326.
Jabir, N., Khan, F., & Tabrez, S. (2018). Cholinesterase targeting by polyphenols: a therapeutic approach for the treatment of Alzheimer’s disease. CNS Neuroscience & Therapeutics, 24, 753–762.
Islam, M., Tabrez, S., Jabir, N., Ali, M., Kamal, M., da Silva Araújo, L., De Oliveira Santos, J., Da Mata, A., De Aguiar, R., & de Carvalho Melo Cavalcante, A. (2018). An insight on the therapeutic potential of major coffee components. Current Drug Metabolism, 19, 544–556.
Adão, R., de Keulenaer, G., Leite-Moreira, A., & Brás-Silva, C. (2013). Cardiotoxicidade associada à terapêutica oncológica: mecanismos fisiopatológicos e estratégias de prevenção. Portuguese Journal of Cardiology, 32, 395–409.
Bamodu, O. A., Huang, W.-C., Tzeng, D. T. W., Wu, A., Wang, L. S., Yeh, C.-T., & Chao, T.-Y. (2015). Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity. Cancer Letters, 364, 125–134.
Nogueira Neto, J. D., Sousa, D. P. d., & Freitas, R. M. (2013). Avaliação do potencial antioxidante in vitro do nerolidol. Revista de Ciências Farmacêuticas Básica e Aplicada, 34, 125–130.
Abramczyk, H., & Brozek-Pluska, B. (2016). New look inside human breast ducts with Raman imaging. Raman candidates as diagnostic markers for breast cancer prognosis: mammaglobin, palmitic acid and sphingomyelin. Analytica Chimica Acta, 909, 91–100.
Enciso, J. M., Sánchez, O., López de Cerain, A., & Azqueta, A. (2015). Does the duration of lysis affect the sensitivity of the in vitro alkaline comet assay? Mutagenesis, 30, 21–28.
Serum oxidative stress markers and genotoxic profile induced by chemotherapy in patients with breast cancer: a pilot study 2015. Available from: https://www.hindawi.com/journals/omcl/2015/212964/.
Fenech, M., Kirsch-Volders, M., Natarajan, A. T., Surralles, J., Crott, J. W., Parry, J., Norppa, H., Eastmond, D. A., Tucker, J. D., & Thomas, P. (2011). Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis, 26, 125–132.
Carrano, A., & Natarajan, A. (1988). International commission for protection against environmental mutagens and carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques. Mutation Research, 204, 379–406.
Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research, 175, 184–191.
Thomas, P., Holland, N., Bolognesi, C., Kirsch-Volders, M., Bonassi, S., Zeiger, E., Knasmueller, S., & Fenech, M. (2009). Buccal micronucleus cytome assay. Nature Protocols, 4, 825–837.
Degnim, A. C., Visscher, D. W., Berman, H. K., Frost, M. H., Sellers, T. A., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., de Groen, P. C., Lingle, W. L., Ghosh, K., Penheiter, L., Tlsty, T., Melton, L. J., Reynolds, C. A., & Hartmann, L. C. (2007). Stratification of breast cancer risk in women with atypia: a Mayo cohort study. Journal of Clinical Oncology, 25, 2671–2677.
Worsham, M. J., Raju, U., Lu, M., Kapke, A., Cheng, J., & Wolman, S. R. (2007). Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clinical Cancer Research, 13, 5474–5479.
Fisher, B., Dignam, J., Wolmark, N., Wickerham, D. L., Fisher, E. R., Mamounas, E., Smith, R., Begovic, M., Dimitrov, N. V., Margolese, R. G., Kardinal, C. G., Kavanah, M. T., Fehrenbacher, L., & Oishi, R. H. (1999). Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet, 353, 1993–2000.
Lee, Y., Shin, H., Bae, E., & Lim, H. (2016). Aspects of health-related factors and nutritional care needs by survival stage among female cancer patients in South Korea. PLoS One, 11, e0163281.
Alencar, M. V. O. B. d., Silva, M. B. S., Paz, M. F. C. J., Moraes, G. P. d., Nunes, A. T., & Cavalcante, A. A. d. C. M. (2013). Genotoxicidade e nefrotoxicidade da Morinda citrifolia em estudos pré-clínicos: riscos à saúde pública. Revista Interdisciplinar, 6, 1–8.
Paz, M. F. C. J., Alencar, M. C. O., Soares, R. L. L., Costa, D. A. F., Nunes, A. T., & Cavalcante, A. A. C. M. (2013). Avaliação tóxica, citotóxica, mutagênica e genotóxica do látex da Himatanthus sucuuba: uma questão de saúde pública. Revista Interdisciplinar, 6, 52–61.
Moraes, G. P. d., de Alencar, M. V. O. B., Islam, M. T., da Silva Araujo, L., Gomes, D. C. V., de Carvalho, R. M., Correia, D., Paz, M. F. C. J., Ferreira, P. M. P., de Carvalho Melo-Cavalcante, A. A., Picada, J. N., Ferraz, A., & Grivicich, I. (2016). Toxicogenetic profile of rats treated with aqueous extract from Morinda citrifolia fruits. JMPR, 10, 18–28.
Moraes, G. P. d., Alencar, M. V. O. B. d., Islam, M. T., Araújo, L. d. S., Sobral, A. L. P., Machado, K. d. C., Aguiar, R. P. S. d., Júnior, A. L. G., Corrêa, D., Paz, M. F. C. J., Ferreira, P. M. P., Melo-Cavalcante, A. A. d. C., Ferraz, A., Grivicich, I., & Picada, J. N. (2016). Cytogenotoxic and oxidative status evaluation of Morinda citrifolia. International Archives of Medicine, 9.
Ma, Z., Li, C., Qiao, Y., Lu, C., Li, J., Song, W., Sun, J., Zhai, X., Niu, J., Ren, Q., & Wen, A. (2016). Safflower yellow B suppresses HepG2 cell injury induced by oxidative stress through the AKT/Nrf2 pathway. International Journal of Molecular Medicine, 37, 603–612.
Plati, J., Bucur, O., & Khosravi-Far, R. (2011). Apoptotic cell signaling in cancer progression and therapy. Integrative Biology, 3, 279–296.
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014). Apoptosis and molecular targeting therapy in cancer. BioMed Research International, 2014, 150845.
Sabharwal, R., Verma, P., Syed, M. A., Sharma, T., Subudhi, S. K., Mohanty, S., & Gupta, S. (2015). Emergence of micronuclei as a genomic biomarker. Indian Journal of Medical and Paediatric Oncology, 36, 212–218.
Uriol, E., Sierra, M., Comendador, M. A., Fra, J., Martínez-Camblor, P., Lacave, A. J., & Sierra, L. M. (2013). Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor. Mutagenesis, 28, 39–48.
Adami, H., Hunter, D., & Trichopoulos, D. (2008). Textbook of cancer epidemiology. Oxford: Oxford University Press.
Ferguson, L. R., Chen, H., Collins, A. R., Connell, M., Damia, G., Dasgupta, S., Malhotra, M., Meeker, A. K., Amedei, A., Amin, A., Ashraf, S. S., Aquilano, K., Azmi, A. S., Bhakta, D., Bilsland, A., Boosani, C. S., Chen, S., Ciriolo, M. R., Fujii, H., Guha, G., Halicka, D., Helferich, W. G., Keith, W. N., Mohammed, S. I., Niccolai, E., Yang, X., Honoki, K., Parslow, V. R., Prakash, S., Rezazadeh, S., Shackelford, R. E., Sidransky, D., Tran, P. T., Yang, E. S., & Maxwell, C. A. (2015). Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Seminars in Cancer Biology, 35(Suppl), S5–S24.
Tumas, N., Niclis, C., Aballay, L. R., Osella, A. R., & Díaz, M. d. P. (2014). Traditional dietary pattern of South America is linked to breast cancer: an ongoing case-control study in Argentina. European Journal of Nutrition, 53, 557–566.
Bonassi, S., Coskun, E., Ceppi, M., Lando, C., Bolognesi, C., Burgaz, S., Holland, N., Kirsh-Volders, M., Knasmueller, S., Zeiger, E., Carnesoltas, D., Cavallo, D., da Silva, J., de Andrade, V. M., Demircigil, G. C., Domínguez Odio, A., Donmez-Altuntas, H., Gattas, G., Giri, A., Giri, S., Gómez-Meda, B., Gómez-Arroyo, S., Hadjidekova, V., Haveric, A., Kamboj, M., Kurteshi, K., Martino-Roth, M. G., Montero Montoya, R., Nersesyan, A., Pastor-Benito, S., Favero Salvadori, D. M., Shaposhnikova, A., Stopper, H., Thomas, P., Torres-Bugarín, O., Yadav, A. S., Zúñiga González, G. and Fenech, M. (2011) The human micronucleus project on eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, and assay protocol. Mutation Research, 728, 88–97.
Nikitaki, Z., Nikolov, V., Mavragani, I. V., Plante, I., Emfietzoglou, D., Iliakis, G., & Georgakilas, A. G. (2016). Non-DSB clustered DNA lesions. Does theory colocalize with the experiment? Radiation Physics and Chemistry, 128, 26–35.
Gallego, D. F., Muñoz, C., Jimenez, C. A., & Carrascal, E. (2016). Hepatoid adenocarcinoma of the urachus. Case Reports in Pathology, 2016, 1871807.
Duthie, S. J. (2007). Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process. Molecular Nutrition & Food Research, 51, 665–674.
Lim, U., & Song, M.-A. (2012). Dietary and lifestyle factors of DNA methylation. Methods in Molecular Biology, 863, 359–376.
Hanf, V., & Gonder, U. (2005). Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 123, 139–149.
Masala, G., Assedi, M., Bendinelli, B., Ermini, I., Sieri, S., Grioni, S., Sacerdote, C., Ricceri, F., Panico, S., Mattiello, A., Tumino, R., Giurdanella, M. C., Berrino, F., Saieva, C., & Palli, D. (2012). Fruit and vegetables consumption and breast cancer risk: the EPIC Italy study. Breast Cancer Research and Treatment, 132, 1127–1136.
Oliveira, C. (2012). Avaliação das Atividades Anti-toxoplásmica, Antioxidante e Antiinflamatória dos Momentos Timol (Lippiasidoides) e Estragol (Crotonzenhtneri). Mestrado em Ciências Biológicas, Universidade Federal do Rio Grande do Norte, Natal.
Macêdo, J. (2011). Capacidade Antioxidante in vitro a Avaliação Toxicidade Aguda in vivo de extratos de Folhas de Licania rígida Benth.,Licania Tomentosa (Benth) Fritsch e Couepeia Imprensa Prance (Chrysobalanaceae). Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Norte, Natal.
Knaak, N., & Fiuza, L. (2010). Potencial dos Óleos Essenciais de Plantas no Controle de Insetos e Microrganismo. São Leopoldo, 5, 120–123.
Abderrahim, F., Arribas, S. M., Gonzalez, M. C., & Condezo-Hoyos, L. (2013). Rapid high-throughput assay to assess scavenging capacity index using DPPH. Food Chemistry, 141, 788–794.
Zanon, G. (2010). Análise Fitoquímica e Estudo das Atividades Antimicrobiana, Antioxidante e de Inibição da Enzima Acetilcolinesterase das Espécies ZanthoxylumRhoifolium e ZanthoxylumHyemale. Mestrado em Química: Universidade Federal de Santa Maria, Santa Maria.
Llanes-Coronel, D. S., Gámez-Díaz, L. Y., Suarez-Quintero, L. P., Páez, L. J., Torres, F., Echeverri, F., Ponte-Sucre, A., Patiño, P. J., & Trujillo-Vargas, C. M. (2011). New promising Euphorbiaceae extracts with activity in human lymphocytes from primary cell cultures. Immunopharmacology and Immunotoxicology, 33, 279–290.
Kaiser, J. C., Jacob, P., Meckbach, R., & Cullings, H. M. (2012). Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998. Radiation and Environmental Biophysics, 51, 1–14.
Mannucci, S., Luzzi, A., Carugi, A., Gozzetti, A., Lazzi, S., Malagnino, V., Simmonds, M., Cusi, M. G., Leoncini, L., van den Bosch, C. A., & De Falco, G. (2012). EBV reactivation and chromosomal polysomies: Euphorbia tirucalli as a possible cofactor in endemic Burkitt lymphoma. Adv Hematol, 2012, 149780.
Larrosa, R C. Rau and Duarte MdRR. (2005) Morfoanatomia de folhas de Himatanthus sucuuba (Spruce) Woodson, Apocynaceae. Acta Farmacéutica Bonaerense, 24, 165–171.
Acknowledgements
The authors gratefully acknowledge the research facilities provided by the Federal University at Piauí, Brazil, and King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia.
Author information
Authors and Affiliations
Contributions
Márcia Fernanda Correia Jardim Paz: Performed the experimental work
Antônio Luiz Gomes Júnior: Performed the experimental work
Marcus Vinícius Oliveira Barros de Alencar: Performed the experimental work
Shams Tabrez: Conceived, guided, and proofread the article
Muhammad Torequl Islam: Performed the experimental work and wrote the first draft of the manuscript
Nasimudeen R Jabir: Wrote the first draft of the manuscript and proofread it
Mohammad Oves: Guided the work and helped troubleshoot different experiments
Mohammad Zubair Alam: Guided the work and helped troubleshoot different experiments
Muhammad Nadeem Asghar: Proofread the manuscript and was also involved in the revision
Eunüs S. Ali: Was involved in the statistical analysis
Keylla da Conceição Machado: Wrote the first draft of the manuscript and was also involved in the revision
Kátia da Conceição Machado: Wrote the first draft of the manuscript
Felipe Cavalcanti Carneiro da Silva: Supervised the work and was also involved in the statistical analysis
André Luiz Pinho Sobral: Sample collection, questionnaire filling, and sample handling
João Marcelo de Castro e Sousa: Sample collection, questionnaire filling, and sample handling
Germano Pinho de Moraes: Supervised the work and was also involved in the statistical analysis
Siddhartha Kumar Mishra: Proofread the manuscript
Ana Amélia de Carvalho Melo Cavalcante: Guided the work and wrote the first draft of the manuscript
Juliana da Silva: Proofread the manuscript
Corresponding authors
Ethics declarations
This study was performed in compliance with the Helsinki Declaration and was approved by the Ethics Committee of the Centro de Universitário UNINOVAFAPI 0406.0.043.000-11 (approval number: 0406.0.043.000-11).
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Paz, M.F.C.J., Gomes Júnior, A.L., de Alencar, M.V.O.B. et al. Effect of Diets, Familial History, and Alternative Therapies on Genomic Instability of Breast Cancer Patients. Appl Biochem Biotechnol 188, 282–296 (2019). https://doi.org/10.1007/s12010-018-2918-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-018-2918-9